AlphaCentric Advisors »

Kymera Therapeutics shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $392k 5.0k 77.81

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Kymera Therapeutics

venBio Select Advisor
Baker Bros. Advisors
Vanguard Group
FMR
BVF
Wellington Management Company
BlackRock
Atlas Venture Life Science Advisors
Siren
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management
Ubs Global Asset Management Americas
Merck & Co

View all funds holding Kymera Therapeutics